Astellas shakes structure of R&D division

Japanese pharmaceutical company Astellas plans to implement a more flat structure in its research and development division in pursuit of developing new, innovative medicaments.
Astella's office in Denmark. | Photo: Astellas / PR
Astella's office in Denmark. | Photo: Astellas / PR

Japanese pharmaceutical firm Astellas moves to reform its research and development unit in the aim of developing competitive products, the company writes in a press statement.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading